Purdue Pharma

Connecticut Attorney General William Tong has commended the U.S. Supreme Court's decision that the Sackler family — who own Purdue Pharma in Stamford — can’t use the drug company’s bankruptcy to settle opioid lawsuits.

The company and the Sackler family will pay $6 billion over 18 years to victims, survivors and the states involved.

A judge approved the bonuses on Wednesday for more than 480 Purdue Pharma employees based in Stamford. A $3 million raise for CEO and President Craig Landau will be up for review on June 15.

Suffolk County will spend $1 million to plan coastal resiliency projects as the impact of climate change intensifies.

The state was one of eight, along with Washington, D.C., that signed the $6 billion settlement.

Legal protections had been set to expire Thursday, but U.S. Bankruptcy Judge Robert Drain said in a hearing that they'd remain in place through March 23.

A judge Tuesday gave the company 16 more days of protection from lawsuits over the toll of the drugs while the details are worked out.

A judge has ordered another delay in lawsuits against OxyContin maker Purdue Pharma and the company’s owners, the Sackler family.

The judge took issue with a provision in the settlement that would protect members of the Sackler family from facing litigation of their own.

Purdue Pharma has been in bankruptcy court since 2019.